James A Bailey

Colorectal Research Fellow
Nottingham University Hospitals NHS Trust
University of Nottingham

[James A Bailey @JamesA_Bailey]

Open access: Thrombocytosis helps stratify risk of colorectal cancer in patients referred on a 2WW pathway.

Patients with abnormal platelet counts are at higher risk of CRC. Useful for prioritising investigation of symptomatic patients.
@NottinghamColo1
https://t.co/dmzCjcqHku

[James A Bailey @JamesA_Bailey]

@AdiamahAlfred @Humesy10 @mrnigeldsouza More to come soon on our experience with FIT for CRC.

Muchas gracias.

[James A Bailey @JamesA_Bailey]

Our latest paper discussing the first 2 years of incorporating #FIT with blood tests to identify people at higher risk of #bowelcancer in Nottingham.

@NottinghamColo1 @NUHSurgery @BjsOpen @Humesy10

Full Open access article available at link below.
https://t.co/RZYWhVOV55

[James A Bailey @JamesA_Bailey]

Our experiences incorporating FIT into diagnostic pathways for colorectal cancer in Nottingham. FIT allows primary care to select a more appropriate cohort for urgent investigation without a large number of missed diagnoses @NottinghamColo1 @nottmhospitals
https://t.co/5hObNfgDNC